PubMed · 1983 · 147 citations · 16 references
Life SciencesGeneticsMolecular GeneticsEnzymologyHuman GeneticsMedical GeneticsEnzyme CharacterizationPharmacogenetic TestingPopulation PharmacogeneticsEnzyme Activity PolymorphismEnzyme Assay DevelopmentEnzyme Gene VariantsEnzyme Polymorphism Effects
Plasma paraoxonase hydrolyzes paraoxon, the principal metabolite of the insecticide parathione. A genetic polymorphism for enzyme activity has been previously demonstrated. We describe a new assay based on the differential inhibition by EDTA of plasma paraoxonase from persons with the high-activity allele (PX*H) that suggests a trimodality of activity levels in population studies. The gene frequency of the low activity allele (PX*L) in 531 Seattle blood donors of European origin was .7207. Family studies were consistent with codominant autosomal inheritance of two alleles, PX*L (low) and PX*H (high), coding for products with different activity levels. Biochemical measurements of sera from presumed homozygotes for the two different alleles revealed minor physicochemical differences suggestive of a structural difference between the allelic products. No evidence for linkage of the paraoxonase locus with any of 19 polymorphic markers would be detected.
16
Genetic polymorphism and interethnic variability of plasma paroxonase activity.
J. R. Playfer, L. C. Eze, M F Bullen et al. · Journal of Medical Genetics · 1976 · 146 citations · Full text
Chronic inhibition of cholinesterase as a cause of myopathy
Gerald M. Fenichel, W. Ben Kibler, William H. Olson et al. · Neurology · 1972 · 98 citations
Medicine, Biochemistry, Neurology +12